Department of Neurology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Clin Interv Aging. 2023 Mar 27;18:495-503. doi: 10.2147/CIA.S394286. eCollection 2023.
Frontotemporal lobar degeneration (FTLD) is a group of neurodegenerative diseases with heterogenous clinical, genetic, and pathological characteristics that show similar impairment of areas in the frontal and/or temporal lobes. Prime doctors' lack of awareness of this complex disease makes early identification and accurate intervention difficult. Autoimmune diseases and autoantibodies are manifestations of different levels of autoimmune reactions. This review presents research findings examining the relationship between autoimmunity and FTLD in terms of autoimmune diseases and autoantibodies with a focus on identifying potential diagnosis and treatment approaches. The findings indicate that the same or similar pathophysiological mechanisms may exist from clinical, genetic, and pathological perspectives. However, the existing evidence is not sufficient to extract substantial conclusions. On the basis of the current situation, we propose future research patterns using prospective studies on large populations and combined clinical and experimental research. Autoimmune reactions or, more generally, inflammatory reactions should receive increased attention from doctors and scientists of all disciplines.
额颞叶变性(FTLD)是一组具有异质性临床、遗传和病理学特征的神经退行性疾病,表现为额极和/或颞叶区域的相似损伤。主要医生对这种复杂疾病缺乏认识,使得早期识别和准确干预变得困难。自身免疫性疾病和自身抗体是不同程度自身免疫反应的表现。本综述从自身免疫性疾病和自身抗体的角度,就自身免疫与 FTLD 之间的关系,重点探讨了潜在的诊断和治疗方法,介绍了研究结果。研究结果表明,从临床、遗传和病理的角度来看,可能存在相同或相似的病理生理机制。然而,现有证据还不足以得出实质性的结论。基于目前的情况,我们提出了未来的研究模式,使用针对大人群的前瞻性研究和临床与实验研究相结合。自身免疫反应或更一般的炎症反应应引起所有学科的医生和科学家的更多关注。